Trials / Completed
CompletedNCT00742391
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
A Multi-center, Randomized, Parallel Group, Double-blind, Vehicle-controlled Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, 0.05% In Patients With Actinic Keratoses ON Non-head Locations (REGION-I)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 255 (actual)
- Sponsor
- Peplin · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether topical application of PEP005 is effective for the treatment of actinic keratoses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEP005 (ingenol mebutate) Gel | two day treatment |
| DRUG | Vehicle gel | two day treatment |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2008-08-27
- Last updated
- 2015-03-06
- Results posted
- 2012-03-21
Locations
20 sites across 2 countries: United States, Australia
Source: ClinicalTrials.gov record NCT00742391. Inclusion in this directory is not an endorsement.